BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezhilarasan D, Lakshmi T, Mallineni SK. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges. Nanomedicine. [DOI: 10.2217/nnm-2021-0364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li T, Zhou T, Liu Y, Wang J, Yu Z. Efficacy analysis of targeted nanodrug for non-small cell lung cancer therapy. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1068699] [Reference Citation Analysis]
2 Habeeb M, Kareem TA, Deepthi KL, Khot VS, Woon YH, Pawar SS. Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways. Journal of Drug Delivery Science and Technology 2022;77:103865. [DOI: 10.1016/j.jddst.2022.103865] [Reference Citation Analysis]
3 Dalan R, Bornstein SR, Boehm BO. Cushing's Disease Management: Glimpse Into 2051. Front Endocrinol (Lausanne) 2022;13:943993. [PMID: 35872988 DOI: 10.3389/fendo.2022.943993] [Reference Citation Analysis]